Position in BMY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$531,602
-$43,481 QoQ
Shares Held
9,226
-2.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,492
of 2,506 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bison Wealth, LLC holds $18,729,734 across 7 Drug Manufacturers - General names. BMY ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,530 | $4,233,988 | |
| 2 | JNJ |
Johnson & Johnson
|
15,712 | $3,990,376 | |
| 3 | ABBV |
AbbVie Inc.
|
15,394 | $3,873,746 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,444 | $3,398,054 | |
| 5 | AMGN |
Amgen Inc
|
6,418 | $2,324,086 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
9,226 | $531,602 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,991 | $377,882 |
All Filings in BMY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $531,602 | 9,226 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $575,083 | 9,482 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $518,794 | 9,618 | Shares | Sole | 2026-03-24 | |
| 2025-09-30 | $200,785 | 4,452 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||